Erin L. J. Alston & Debra L. Zynger. (2019). Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ? BMC.
Chicago Style (17th ed.) CitationErin L. J. Alston and Debra L. Zynger. Does the Addition of AMACR to CK20 Help to Diagnose Challenging Cases of Urothelial Carcinoma in Situ? BMC, 2019.
MLA (9th ed.) CitationErin L. J. Alston and Debra L. Zynger. Does the Addition of AMACR to CK20 Help to Diagnose Challenging Cases of Urothelial Carcinoma in Situ? BMC, 2019.
Warning: These citations may not always be 100% accurate.